Open AccessDual-Acting Peptides Target EZH2 and AR: A New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer
Author(s) -
Zhengyang Han,
Ujjwal Rimal,
Prabesh Khatiwada,
Jacob Brandman,
Jun Zhou,
Muhammad S. Hussain,
Ronald E. Viola,
Lirim Shemshedini
Publication year - 2022
Publication title -
endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.674
H-Index - 257
eISSN - 1945-7170
pISSN - 0013-7227
DOI - 10.1210/endocr/bqac180
Subject(s) - enzalutamide , prostate cancer , ezh2 , cancer research , medicine , cancer , androgen receptor , prc2 , biology , epigenetics , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom